Amacna, Caryl Jane E.

HRN: 21-09-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2026
METRONIDAZOLE 500MG (TAB)
01/21/2026
01/28/2026
PO
500mg
TID X 7 Days
S/P NSVD; Thickly MSAF
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines